Example: dental hygienist

坂根直樹(さかねなおき) - yobouigaku-kyoto.jp

1989 . 1989 . 1991 . 1993 . 1994 . 1995 . 1998 . 1999 . 2001 . 2003 .. 11 1996 . 8 1998 . 10 1998 . 5 1999 . 12 . 2000 . 2000 . 1 2008 . 2010 .. 1. 50 2013. 2. Dr. 2009. 3. 50 2005. 4.. 2003. 5. 2007. 6. ! 2010. 7. Dr. ! ! ! 2010 DVD iPad . 8. 100 2004. 9. 2008. 10. 2011. 11. 3 2008. 12. 2011. 13. 2015 81 .. 196 86 144 .. 1. Sakane N, et al: Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial. BMJ Open. 2015; 5(8): e007316. 2. Sakane N, et al: Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program.

坂根直樹(さかねなおき) 独立行政法人国立病院機構京都医療センター臨床研究センター予防医学研究室 室長

Tags:

  Yobouigaku

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of 坂根直樹(さかねなおき) - yobouigaku-kyoto.jp

1 1989 . 1989 . 1991 . 1993 . 1994 . 1995 . 1998 . 1999 . 2001 . 2003 .. 11 1996 . 8 1998 . 10 1998 . 5 1999 . 12 . 2000 . 2000 . 1 2008 . 2010 .. 1. 50 2013. 2. Dr. 2009. 3. 50 2005. 4.. 2003. 5. 2007. 6. ! 2010. 7. Dr. ! ! ! 2010 DVD iPad . 8. 100 2004. 9. 2008. 10. 2011. 11. 3 2008. 12. 2011. 13. 2015 81 .. 196 86 144 .. 1. Sakane N, et al: Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial. BMJ Open. 2015; 5(8): e007316. 2. Sakane N, et al: Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program.

2 BMJ Open Diabetes Res Care. 2014; 2(1): e000003. 3. Sakane N, et al: Beta2-adrenoceptor gene polymorphism and obesity. Lancet. 1999;. 353:1976. 4. Sakane N, et al: Glitazones and NIDDM. Lancet. 1997; 349: 952. 5. Yoshida T, Sakane N, et al: Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet. 1995; 346: 1433-4. 6. Sakane N, et al: Reversible hypopituitarism after interferonalfa therapy. Lancet. 1995; 345:1305. 7. Sakane N, et al: Beta3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome.

3 Diabetologia. 1997; 40(2): 200-4. 8. Sakane N, et al: Effects of Trp64 Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care. 1997; 20(12): 1887-90.. 2 NHK . 2008 4 2 . NHK 2008 8 31 .. NHK 2014 4 1 . 2015 8 3 6 . NHK . 2015 10.


Related search queries